Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2024 Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2024 Earnings Call Transcript November 7, 2024

Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.33.

Operator: Hello, and thank you for standing by. Welcome to Allogene Therapeutics’ Third Quarter 2024 Conference Call. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to turn the call over to Christine Cassiano, Chief...